Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information

Commentary: Molecular testing in melanoma

(2014) David M. Miller et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects

(2014) K. G. Griewank et al.   JNCI-Journal of the National Cancer Institute

Molecular biomarkers of prognosis in melanoma

(2013) Sarah-Jane Schramm et al.   MELANOMA RESEARCH

MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy

(2012) M. F. Segura et al.   CARCINOGENESIS

New therapies in the treatment of melanoma

(2012) Diwakar Davar et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Melanoma: New Insights and New Therapies

(2012) Vasiliki A. Nikolaou et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma

(2012) Graham J. Mann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Biospecimen banking: The pathway to personalized medicine for patients with cancer

(2012) Richard A. Scolyer et al.   JOURNAL OF SURGICAL ONCOLOGY

Melanoma molecular classes and prognosis in the postgenomic era

(2012) Elisa Tremante et al.   LANCET ONCOLOGY

Narrowing the knowledge gaps for melanoma

(2012) Ana Slipicevic et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis

(2011) Sarah-Jane Schramm et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer

(2011) Gery P. Guy et al.   PHARMACOECONOMICS

2010 TNM Staging System for Cutaneous Melanoma…and Beyond

(2010) Jeffrey E. Gershenwald et al.   ANNALS OF SURGICAL ONCOLOGY

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

(2010) József Tímár et al.   CLINICAL & EXPERIMENTAL METASTASIS

Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome

(2010) G. Jonsson et al.   CLINICAL CANCER RESEARCH

Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

(2010) M. F. Segura et al.   CLINICAL CANCER RESEARCH

MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma

(2010) Stefano Caramuta et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers

(2010) Katja A. Matheis et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma

(2009) Rajmohan Murali et al.   ANNALS OF SURGERY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

(2009) D. Bogunovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A kernel-based integration of genome-wide data for clinical decision support

(2009) Anneleen Daemen et al.   Genome Medicine

Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma

(2008) T. John et al.   CLINICAL CANCER RESEARCH

Melanoma epidemiology and trends

(2008) Claus Garbe et al.   CLINICS IN DERMATOLOGY

Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment

(2008) Rajmohan Murali et al.   Future Oncology